Plus $5 million share buyback and 3-cent per share dividend, a 50% increase from last quarter. Great company.
Read the latest news release and listen to the cc on ITEK website, you will understand why the share price has been shooting up so quickly and changing hands at such huge volume (multiple times of ITEK's 16 million shares outstanding). Institutions have recognized trabodenoson's great promise, the Phase 3 design is brilliant and will not take long. The trial result will be out in 2006. I haven't sold a single share and happy to ride it all the way UP... I will be buying more if it falls back to my target price.
Shorts only have one day to cover and this is their last attempt. If you look at 7/14/15 trading volume after the company revenue news, the 1.6 million historic volume tells you how optimistic investors are about the near-term prospect. On the down days following that, volumes are lower and lower. I believe the up days are imminent. Hold on to your golden egg.
That will be money WASTED for a long time, let alone the opportunity cost. Better put your hard-earned cash in NHTC, a fast-growing company that has recently been uplisted on Nasdaq and is announcing another great quarter of operation tomorrow (5/5/14).
GRAND HAVEN, MI –The former chairman and founder of Macatawa Bank Corp., is suing the Holland bank holding company for severance payments that were suspended in 2010 after the bank suffered heavy losses.
Benjamin Smith, who was promised $20,833.33 a month for six years after he left Macatawa Bank in 2009, has filed a lawsuit in Ottawa County Circuit Court to have those payments resumed now that the bank is back in the black and paying its shareholders a dividend.
I have made over $7,000 on NHTC over the past year. This will allow me to make over $12,000-15,000 in about a week. The lower the pps the better for buyers like me.
In a research report shared with investors by Suntrust Robinson on Wednesday (7/15/15), James River Group Holdings Ltd (NASDAQ:JRVR) had its target price upped to $33.00. The firm now has Buy rating on the stock.
Total revenues increased 104% to $69.7 million, compared to $34.2 million in the second quarter last year. Net income was $12.3 million, or $0.98 per diluted share, compared to $6.1 million, or $0.49 per diluted share, in the second quarter last year.
"Our Hong Kong business continues to excel, and to date, the economic slowdown in China has not impacted us," continued Mr. Sharng. "In the long term, we feel that the re-orientation of the Chinese economy toward consumption is good for businesses like ours, as we work to introduce high-quality consumer products to the increasingly affluent Chinese consumers. We are in the Chinese market for the long haul and are bullish on its prospect."
"Further, during the quarter, we funded the required deposit for the consumer protection fund in China, which is a prerequisite to submitting our direct selling license application," concluded Mr. Sharng. "We view applying for a direct selling license as strategically valuable to help us drive incremental growth as our brand recognition continues to grow in China and Asia."